Kosel M, Eap C B, Amey M, Baumann P
Unité de Biochimie et Psychopharmacologie Clinique, Département Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland.
J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):234-8. doi: 10.1016/s0378-4347(98)00384-3.
A procedure using a chirobiotic V column is presented which allows separation of the enantiomers of citalopram and its two N-demethylated metabolites, and of the internal standard, alprenolol, in human plasma. Citalopram, demethylcitalopram and didemethylcitalopram, as well as the internal standard, were recovered from plasma by liquid-liquid extraction. The limits of quantification were found to be 5 ng/ml for each enantiomer of citalopram and demethylcitalopram, and 7.5 ng/ml for each enantiomer of didemethylcitalopram. Inter- and intra-day coefficients of variation varied from 2.4% to 8.6% for S- and R-citalopram, from 2.9% to 7.4% for S- and R-demethylcitalopram, and from 5.6% to 12.4% for S- and R- didemethylcitalopram. No interference was observed from endogenous compounds following the extraction of plasma samples from 10 different patients treated with citalopram. This method allows accurate quantification for each enantiomer and is, therefore, well suited for pharmacokinetic and drug interaction investigations. The presented method replaces a previously described highly sensitive and selective high-performance liquid chromatography procedure using an acetylated 3-cyclobond column which, because of manufactural problems, is no longer usable for the separation of the enantiomers of citalopram and its demethylated metabolites.
本文介绍了一种使用手性生物V柱的方法,该方法可分离西酞普兰及其两种N-去甲基代谢物的对映体以及内标阿普洛尔在人血浆中的对映体。通过液-液萃取从血浆中回收西酞普兰、去甲基西酞普兰和双去甲基西酞普兰以及内标。发现西酞普兰和去甲基西酞普兰各对映体的定量限为5 ng/ml,双去甲基西酞普兰各对映体的定量限为7.5 ng/ml。S-和R-西酞普兰的日间和日内变异系数在2.4%至8.6%之间,S-和R-去甲基西酞普兰的日间和日内变异系数在2.9%至7.4%之间,S-和R-双去甲基西酞普兰的日间和日内变异系数在5.6%至12.4%之间。从10名接受西酞普兰治疗的不同患者的血浆样本中提取后,未观察到内源性化合物的干扰。该方法可对各对映体进行准确定量,因此非常适合药代动力学和药物相互作用研究。所介绍的方法取代了先前描述的使用乙酰化3-环糊精柱的高灵敏度和高选择性高效液相色谱方法,由于制造问题,该柱不再可用于分离西酞普兰及其去甲基代谢物的对映体。